Peer Review History
| Original SubmissionFebruary 2, 2022 |
|---|
|
PONE-D-22-03341Consumer Acceptance of New Plant-Breeding Technologies: An Application to the Use of Gene Editing in Fresh Table GrapesPLOS ONE Dear Dr. Gallardo, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Reviewer #2 have provided important comments to improve this manuscript. I would like to ask you to response to those comments properly. Please submit your revised manuscript by May 09 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Hiroshi Ezura Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please ensure that you include a title page within your main document. We do appreciate that you have a title page document uploaded as a separate file, however, as per our author guidelines (http://journals.plos.org/plosone/s/submission-guidelines#loc-title-page) we do require this to be part of the manuscript file itself and not uploaded separately. Could you therefore please include the title page into the beginning of your manuscript file itself, listing all authors and affiliations. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: [This work is supported in part by the USDA National Institute of Food and Agriculture - Specialty Crop Research Initiative project “VitisGEN2” (2017-51181-26829).] We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [RKG, BR, JA received funding USDA National Institute of Food and Agriculture - Specialty Crop Research Initiative project “VitisGEN2” (2017-51181-26829) https://nifa.usda.gov/funding-opportunity/specialty-crop-research-initiative-scri NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.] Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 6. We note that you have referenced (ie. Bewick et al. [5]) which has currently not yet been accepted for publication. Please remove this from your References and amend this to state in the body of your manuscript: (ie “Bewick et al. [Unpublished]”) as detailed online in our guide for authors http://journals.plos.org/plosone/s/submission-guidelines#loc-reference-style. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this manuscript entitled "Consumer Acceptance of New Plant-Breeding Technologies: An Application to the Use of Gene Editing in Fresh Table Grapes", the authors estimate the willingness to pay for genetic traits and other attributes of table grape in comparison with the conventional breeding method and the gene editing. This study on the estimation of willingness to pay of a large number of more than 2,800 consumers based on a wide decision branches in breeding techniques, agricultural management, and product value in biotechnology foods developed with fruit trees that take time to breed will provide important light on for future development goal of biotech plants using genome editing and for planning the better way to market them. The investigation and statistical analysis are well performed, and the results are convincing. I have a few relatively minor comments, explained below. -The first letter of both Genetically Engineering and Gene Editing is "GE". Although there is a definition in the manuscript, it may cause confusion to reader, so could the author change the abbreviation to something more clear? -The term "Fig" should have a period in it. Please consider this across the manuscript. -For example on Page 4, line 5 in Background section, since hyphens are used in other CRISPR, "CRISPR/Cas9" should be replaced with a hyphen. Please consider this across the manuscript. -In the characteristics of the survey in Table 3 on page 14, there seems to be a tendency for those in "Education" to be slightly more educated and those in "Income" to have higher income. It may expected that this tendency has some influence on the acceptance of biotech foods. What is the author's opinion on this point? You don't necessarily have to answer. -In the Table 4 on page 16, a total of 9.3% of the respondents have a consumption frequency of 2-3 times a year or less than 2-3 times a year. How do these consumers conduct their consumption activities? -The hindmost sentence of the first paragraph on the page 27 has no period. Reviewer #2: This paper analyses consumers’ preferences with regard to fresh produce by comparing gene-edited table grapes and grapes bred by conventional breeding methods. Using consumers’ willingness to pay for attributes of table grapes, especially paying attention to attributes of quality such as taste and texture and agronomic characteristics such as the number of chemical applications, the paper identifies hierarchies among the identified attributes and substantiates them with empirical data. The justification of why fresh table grapes were chosen for this study is logically sound and persuasive; thus readers who are interested in carrying out similar studies using other kinds of produce can see to what extent and how the proposed analytical framework can be used for their studies. The main contribution of the paper is to advance knowledge about consumer acceptance of gene-edited foods. The topic is important and timely considering the fact that gene-edited foods are beginning to be introduced to the market in some parts of the world. In addition, I would like to add that the significance of this study is that the paper has succeeded in analytically and empirically unbundling the relevant attributes of gene-edited table grapes, which previously were bundled together as simply produce that has merits for producers or consumers. Unfortunately, my expertise does not allow me to evaluate the statical analysis performed for this paper, thus I defer on this to the other reviewers who have the relevant background. I have chosen “yes” for most of the review questions in the Plos One editorial manager but have chosen “partly” for the question that asks “Is the manuscript technically sound, and do the data support the conclusions?” Given that, I recommend that this paper be accepted for publication with major revision. The reason I have chosen “partly” for the technical soundness of this manuscript pertains to the ways in which the review of literature is organized. While the review concerning the empirical approach is elaborate, reviews of the key concepts are somewhat insufficient. I see that some of the fundamental and recent papers in the field that examines consumer acceptance, or more broadly public acceptance, of breeding technologies, are not included in this paper, though the authors suggest that the main contribution of the paper is to advance the knowledge about consumer acceptance of new plant-breeding technologies, building on what has been done previously. I agree that studies of consumer acceptance of gene-edited foods are an emerging field of study, and thus scholarship on this particular topic is not as solid as for other fields of study such as consumer acceptance of genetically modified foods, cisgenics, mutagenesis, or organic thereof, but these existing studies are quite relevant and useful for this paper. Depending on how the authors want to organize this section, the authors could expand on the fields of application of gene editing technologies to animals, as studies of public views on gene edited animals are quite extensive and could again provide useful insights for the present paper. Alternatively, the paper can bring in literature that sheds light on citizens', the public's or stakeholders’ views of gene edited crops and foods; this should help readers to situate the topic of consumer acceptance of gene-edited foods within the broader literature. Additionally, I would like to point out that some of the interesting points raised in the “background” section (from third line, page 6 onwards) that begins “Our research is motivated by questions regarding the …” could be moved to the next section (“Consumer response to food produced with gene editing”) so as to add additional dimensions to the discussion of consumer response. In short, you might want to consider reorganizing the earlier sections of the paper so that the research questions for this paper are clearly laid out before the paper walks readers through its empirical approach. Lack of clarification of the key concepts in this paper seems to have had some ramifications for the discussion in the concluding section. I was slightly confused by some of the points raised in the conclusion. For instance, the first sentence of paragraph three introduces a point that alludes to a relationship between consumer resistance and awareness of benefits associated with GE, but it is not clear where this point in the conclusion stemmed from in terms of the earlier presentation of the data or in terms of its relationship to the existing literature. Another example would be the point raised in the final paragraph of the concluding section that says “Second, gene editing is expected to face some barriers in the marketplace, emphasizing the idea that main opponents will remain opposing these technologies.” I might’ve missed it, but it is not clear why the authors expect barriers to be present in the marketplace and who the main opponents are. Finally, correction or further clarification is required in these specific spots: 1. Page 5, Line 7~8: “…the use of GE breeding techniques in humans and animals is of concern for some groups…” 2. Page 6, Line 21~22: “A version to GE foods varies among products and across consumers, and this variation depends largely on the direct benefit perceived by consumers, their…” It is not clear what “a version” means in this instance. 3. Page 28, Line 11: “The list of food products included fresh table grapes, fresh milk and raw potatoes, and also processed versions of each product (namely grape juice, ice cream, and French fries).” It is not clear why grapes are compared with milk and potatoes. In summary, although the earlier section of the paper needs to be reorganized, I believe that the authors should be able to address these appropriately with modifications to the text. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Consumer Acceptance of New Plant-Breeding Technologies: An Application to the Use of Gene Editing in Fresh Table Grapes PONE-D-22-03341R1 Dear Dr. Gallardo, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hiroshi Ezura Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: All of suggestions have been appropirately incorpoted in the revised manuscript. If I may, I would like to suggest authors to add a sentence or two (page 6, second paragraph) to explain why authors think it is useful to build your study on the studies of gene editring animals, while the theme of paper is "consumer acceptance of plants gene editing". Demonstrating how two bodies of literature connect to one another should stregthen your argument. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-22-03341R1 Consumer Acceptance of New Plant-Breeding Technologies: An Application to the Use of Gene Editing in Fresh Table Grapes Dear Dr. Gallardo: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Hiroshi Ezura Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .